Telmisartan inhibits hepatocellular carcinoma cell proliferation in vitro by inducing cell cycle arrest

Hepatocellular carcinoma (HCC) is the most common primary malignancy of the liver and the third leading cause of cancer-related death. Telmisartan, a widely used antihypertensive drug, is an angiotensin II type 1 (AT1) receptor blocker (ARB) that might inhibit cancer cell proliferation, but the mech...

Descripción completa

Detalles Bibliográficos
Autores principales: Oura, Kyoko, Tadokoro, Tomoko, Fujihara, Shintaro, Morishita, Asahiro, Chiyo, Taiga, Samukawa, Eri, Yamana, Yoshimi, Fujita, Koji, Sakamoto, Teppei, Nomura, Takako, Yoneyama, Hirohito, Kobara, Hideki, Mori, Hirohito, Iwama, Hisakazu, Okano, Keiichi, Suzuki, Yasuyuki, Masaki, Tsutomu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5780034/
https://www.ncbi.nlm.nih.gov/pubmed/29048654
http://dx.doi.org/10.3892/or.2017.5977

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5780034/
https://www.ncbi.nlm.nih.gov/pubmed/29048654
http://dx.doi.org/10.3892/or.2017.5977

Ejemplares similares